Table 1.
Showing baseline demographics, co-morbidities, procedural complications.
| Analyte | TMVR | OMVR |
|---|---|---|
| Demographics | ||
| Sample n (%) | 1120 (6%) | 18,460 (94%) |
| Age with range (years) | 62.7 ± 15.3 | 70.65 ± 13.17 years |
| Males n (%) | 330 (29.4%) | 6920 (37.4%) |
| Females n (%) | 520 (46.4%) | 8375 (45.3%) |
| Caucasians | 74% | 73.00% |
| African Americans | 11% | 12% |
| Others race | 8% | 9% |
| Median household Income 1st Quartile: 1–43,999$ n (%) | 245 (22.1%) | 5020 (27.8%) |
| MHI 2nd Quartile: 44,000–55,999$ (n%) | 315 (28.4%) | 4735 (26.2%) |
| MHI 3rd Quartile: 56,000–73,999$ n (%) | 260 (23.4%) | 4320 (23.9%) |
| MHI 4th Quartile: >74,000$ n (%) | 290 (26.1%) | 3965 (22.0%) |
| New admission for sole purpose of procedure n (%) | 880 (78.6%) | 15,700 (85.3%) |
| Transfer in from acute facility n (%) | 210 (18.8%) | 2345 (12.7%) |
| Transfer in from non-acute facility n (%) | 30 (2.7%) | 370 (2.0%) |
| No transfer out to other facility n (%) | 825(73.7%) | 12705(68.8%) |
| Transfer to acute care facility n (%) | 5 (0.4%) | 260 (1.4%) |
| Transfer out to non-acute care facility n (%) | 290 (25.9%) | 5490 (29.7%) |
| Baseline Comorbidities n (%) | ||
| Hypertensive heart disease with heart failure I110 | 25 (2.2%) | 200 (1.1%) |
| Hypertension and chronic kidney disease I-V | 25 (2.2%) | 290 (2.3%) |
| Rheumatic valvular disease | 170 (14%) | 6175 (33.4%) |
| Nonrheumatic valvular disease | 275 (24.5%) | 5980 (32.5%) |
| Procedural Characteristics | ||
| Number of Days from admission to procedure | 2.6 ± 4.5 | 3 ± 5 |
| Length of hospital stay (days) | 11.5 ± 10 | 14 ± 12.7 |
| Total Cost ($) | 318,882 | 38,341 |
| Procedural Complications n (%) | ||
| Sepsis due to MSSA | 10 (0.9%) | 140 (0.8%) |
| Sepsis secondary to other strep and staph | – | 240 (1.3%) |
| Sepsis secondary to gram negative infection and candida | – | 200 (1.08%) |
| Acute and subacute infective endocarditis | 45 (4%) | 900 (4.9%) |
| Atrial fibrillation | 10 (0.8%) | 85 (0.5%) |
| STEMI | 20 (1.7%) | 120(0.7%) |
| NSTEMI | 50 (4.5%) | 455 (2.5%) |
| Heart Failure | 125 (1.1%) | |
| Leakage/mechanical complication of prosthesis | 100 (8.9%) | 315 |
| Infection/thrombosis of prosthesis/other complications | 260 (23.2%) | 1215 |